IQ-AI LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.4 GBX | 0.00% |
|
0.00% | -70.21% |
| May. 23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
| May. 20 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
IQ-AI Limited is a Jersey-based company, which is engaged in the provision of clinical treatments to patients in the field of medical imaging diagnostics, based on technology. The Company operates through two segments: holding company expenses and medical software. Its subsidiaries include Imaging Biometrics, LLC and Stone Checker Software Limited. Imaging Biometrics, LLC is a healthcare imaging software company. In addition to providing regulatory consulting services, Imaging Biometrics, LLC supplies medical technology solutions and has a neuroimaging product portfolio. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention.
Calendar
10:00am
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -70.21% | 3.97M | |
| -24.88% | 7.74B | |
| +71.33% | 4.39B | |
| +2.96% | 2.61B | |
| -7.18% | 2.53B | |
| -44.46% | 2.22B | |
| -14.52% | 1.8B | |
| -21.29% | 1.54B | |
| +17.46% | 1.23B | |
| -43.89% | 1.15B |
- Stock Market
- Equities
- IQAI Stock
- News IQ-AI Limited
- IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback
